Summit Investment Advisors Inc. bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 42,614 shares of the company’s stock, valued at approximately $1,292,000.
Several other institutional investors also recently bought and sold shares of BBWI. IFM Investors Pty Ltd purchased a new stake in Bath & Body Works during the 1st quarter worth $1,314,000. Amundi lifted its stake in shares of Bath & Body Works by 382.1% during the first quarter. Amundi now owns 174,951 shares of the company’s stock worth $4,872,000 after purchasing an additional 138,664 shares in the last quarter. Nuveen LLC purchased a new stake in shares of Bath & Body Works in the first quarter worth about $23,273,000. Voya Investment Management LLC grew its stake in shares of Bath & Body Works by 180.5% in the first quarter. Voya Investment Management LLC now owns 110,405 shares of the company’s stock valued at $3,347,000 after buying an additional 71,051 shares in the last quarter. Finally, Shellback Capital LP raised its holdings in shares of Bath & Body Works by 67.0% during the 1st quarter. Shellback Capital LP now owns 668,000 shares of the company’s stock valued at $20,254,000 after buying an additional 268,000 shares during the period. 95.14% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research firms have weighed in on BBWI. UBS Group decreased their price target on Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating for the company in a report on Friday, August 29th. Wells Fargo & Company decreased their target price on shares of Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating for the company in a research note on Monday, October 27th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $26.00 price target on shares of Bath & Body Works in a research note on Monday, October 6th. Citigroup cut their price objective on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a report on Tuesday, August 19th. Finally, Morgan Stanley upped their price objective on shares of Bath & Body Works from $40.00 to $43.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Eleven analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $38.18.
Bath & Body Works Price Performance
Shares of BBWI stock opened at $21.93 on Wednesday. The firm has a fifty day moving average of $26.01 and a two-hundred day moving average of $28.70. The firm has a market cap of $4.52 billion, a P/E ratio of 6.51, a P/E/G ratio of 0.86 and a beta of 1.53. Bath & Body Works, Inc. has a 1-year low of $21.82 and a 1-year high of $41.87.
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. During the same quarter in the prior year, the business posted $0.37 EPS. The company’s revenue for the quarter was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.
Bath & Body Works Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 3.6%. The ex-dividend date of this dividend is Friday, November 21st. Bath & Body Works’s dividend payout ratio (DPR) is currently 23.74%.
Bath & Body Works Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
See Also
- Five stocks we like better than Bath & Body Works
- Most Volatile Stocks, What Investors Need to Know
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- Ride Out The Recession With These Dividend Kings
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
- Election Stocks: How Elections Affect the Stock Market
- BigBear.ai Stock Is Range-Bound—Wall Street Isn’t Buying the Hype
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
